Blau Farmaceutica stock holds at BRL 10.55 as metrics emerge

Published on 09/22/2026 at 08:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Blau Farmaceutica stock stood at BRL 10.55 on September 21, 2026, with a 2.89 percent 12-month gain. Its net margin was 13.09 percent.

Blau Farmaceutica, BRBLAUACNOR1, Illustration mit AI erstellt.

Blau Farmaceutica stock was quoted at BRL 10.55 on September 21, 2026, while the shares showed a 2.89 percent gain over the preceding 12 months. The company is identified by ISIN BRBLAUACNOR1 and trades under ticker BLAU3 on the Brazilian market.

Profitability remains measurable

For the latest available market snapshot dated September 21, 2026, Blau Farmaceutica carried a price-to-earnings ratio of 10.52 and a price-to-book ratio of 1.05. The same snapshot reported a 13.09 percent net margin and a 10.02 percent return on equity, giving investors two concrete measures of profitability and capital efficiency.

Dividend yield adds context

The quoted 12-month dividend yield was 8.74 percent on September 21, 2026. That figure is higher than the 2.89 percent 12-month share-price performance reported in the same market snapshot, although the two measures describe different periods and should not be treated as equivalent returns.

Stock remains at BRL 10.55

Blau Farmaceutica stock stood at BRL 10.55 on September 21, 2026, on the Brazilian market. The dated price, 2.89 percent 12-month performance, 13.09 percent net margin and 8.74 percent dividend yield provide the clearest quantified reference points for the shares.